| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Trospium chloride 20 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Oxybutynin hydrochloride 2.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Oxybutynin hydrochloride 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Oxybutynin hydrochloride 3 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Propiverine hydrochloride 15 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Atropine sulfate 10 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Atropine sulfate 10 mg/g eye ointment |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Cyclopentolate hydrochloride 5 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Homatropine hydrobromide 10 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Homatropine hydrobromide 20 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| papaveretum + skopolaminhydrobromid |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Atropine sulfate 1.25 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Atropine sulfate 5 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Atropine sulfate 20 mg/mL eye drops |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 150 microgram oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Hyoscine methylbromide 2.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 400 microgram oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Propantheline bromide 7.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Mepenzolate bromide 25 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely dicycloverine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely atropine sulfate 400 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely benzatropine mesilate 500 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Orphenadrine citrate 100 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Hyoscyamine sulfate 375 microgram oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Benzatropine mesilate 1 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Homatropine methylbromide 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Homatropine methylbromide 10 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Dicycloverine hydrochloride 20 mg oral capsule |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat + edrofoniumklorid |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely solifenacin succinate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Solifenacin succinate 5 mg oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely trospium chloride 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| otiloniumbromid |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Fesoterodine fumarate 8 mg prolonged-release oral tablet |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Ipratropium bromide 21 microgram/actuation nasal spray |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Oxybutynin hydrochloride 1 mg/mL oral solution |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Procyclidine hydrochloride 500 microgram/mL oral solution |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely procyclidine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Product containing precisely oxybutynin hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat 1,25 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat 1 mg/10 ml, injektionsvätska, lösning, spruta |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| skopolaminbutylbromid 20 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat 1 mg/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat 3 mg/10 ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| atropinsulfat 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| procyklidinhydroklorid 10 mg/2 ml, injektionsvätska, lösning, ampull |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| aklidiniumbromid 375 mikrogram/dos, inhalationspulver |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Ipratropium bromide 20 microgram/actuation pressurized solution for inhalation |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|
| Ipratropium bromide 40 microgram/actuation pressurized solution for inhalation |
Is a |
False |
Product containing muscarinic receptor antagonist (product) |
Inferred relationship |
Some |
|